Caught Our Notice: Oops — paper included proofreader’s query

Via Wikimedia

Title: Concise Review: Mesenchymal Stem Cells in Neurodegenerative Diseases

What Caught Our Attention: Everyone makes mistakes — but some are more amusing than others. In one recent correction, the publisher (Wiley) admitted to including a proofreader’s query in the published manuscript. But didn’t say what the query was.

We looked around, and think we found the added notes in the abstract on the PubMed entry (emphasis ours):  Continue reading Caught Our Notice: Oops — paper included proofreader’s query

The “phantom reference:” How a made-up article got almost 400 citations

Here’s a mystery: How did a nonexistent paper rack up hundreds of citations?

Pieter Kroonenberg, an emeritus professor of statistics at Leiden University in The Netherlands, was puzzled when he tried to locate a paper about academic writing and discovered the article didn’t exist. In fact, the journal—Journal of Science Communications—also didn’t exist.

Perhaps Kroonenberg’s most bizarre discovery was that this made-up paper, “The art of writing a scientific article,” had somehow been cited almost 400 times, according to Clarivate Analytics’ Web of Science.

Anne-Wil Harzing, a professor of International Management at at Middlesex University in London, who recounted Kroonenberg’s discovery in her blog, wrote: Continue reading The “phantom reference:” How a made-up article got almost 400 citations

Journal silently fixes emergency care paper — after misleading press coverage

Last month, a colleague of emergency medicine doctor Daniel Waxman sent him some newly reported findings that took him by surprise. Waxman knew from the title of a press release about the recent paper — “Nearly Half of U.S. Medical Care Comes From Emergency Rooms” — that something was wrong.

Immediately I said, that’s not true. It’s just crazy.

Waxman quickly realized the mistake: The data were based only on care provided in hospitals — much of which, not surprisingly, originates from emergency departments (EDs). But the title of the paper, the abstract, and other places in the text do not specify that. What’s more,  the press release about the study says the findings relate to “all medical care.” The journal has since changed the paper, including the title, to make that distinction clear, but not provided any editorial notice indicating the text had been updated. Meanwhile, the press release and news stories about the original study continue to report the “surprising” original findings.

Continue reading Journal silently fixes emergency care paper — after misleading press coverage

Lawyers call libel suit against journal and critic “lawless” but “well written”

Mark Jacobson

A $10 million defamation suit filed by a Stanford University professor against a critic and a journal may be an assault on free speech, according to one lawyer, but at least it’s “well written.”

Kenneth White, a lawyer at Southern California firm Brown White & Osborn who frequently blogs about legal issues related to free speech at Popehat, told us:

It’s not incompetently drafted, but it’s clearly vexatious and intended to silence dissent about an alleged scientist’s peer-reviewed article.

Scientists have publicly bemoaned the suit’s existence, as reported by several outlets, including Mashable and Nature. Mark Jacobson, an engineering professor at Stanford, has alleged that he was defamed in a June article published in the Proceedings of the National Academy of Sciences (PNAS), which was critical of a 2015 paper co-authored by Jacobson in the same journal. In a complaint filed Sept. 29 in the Superior Court of the District of Columbia, Jacobson accused the journal’s publisher, the National Academy of Sciences, and the paper’s first author, Christopher Clack, an executive at a renewable energy analysis firm, of libel.

White told us that there are several pitfalls that could trip up the lawsuit, including a DC law that allows defendants an early opportunity to ask the court to dismiss cases muzzling free speech and recover attorneys’ fees. But another attorney said the complaint should at least clear the lowest hurdle in the way of getting to trial. Continue reading Lawyers call libel suit against journal and critic “lawless” but “well written”

Caught Our Notice: Dear peer reviewer, please read the methods section. Sincerely, everyone

Via Wikimedia

Title: Plasma contributes to the antimicrobial activity of whole blood against Mycobacterium tuberculosis

What Caught Our Attention: A big peer review (and perhaps academic mentorship) fail.  These researchers used the wrong anticoagulant for their blood samples, leading them to believe that certain blood components were fighting microbes. The authors counted the number of colonies to show how well or poorly Tuberculin mycobacteria were growing in cultures — but blood samples need anticoagulants to prevent clots before analysis, and they used an anticoagulant that actually prevented the microbes from colonizing. The authors (and reviewers) should have known this from  Continue reading Caught Our Notice: Dear peer reviewer, please read the methods section. Sincerely, everyone

Weekend reads: Publishing’s day of reckoning; an Impact Factor discount — on lunch; a prize for negative results

The week at Retraction Watch featured mass resignations from a journal’s editorial board, software that writes papers for you, and a retracted retraction. Here’s what was happening elsewhere: Continue reading Weekend reads: Publishing’s day of reckoning; an Impact Factor discount — on lunch; a prize for negative results

A journal retracted a paper when authors couldn’t pay. Then it retracted the retraction.

Oops.

A plant journal recently retracted a 2017 paper, saying the authors couldn’t pay the page charges ($110/page). The notice has since disappeared, and the journal announced on Twitter Thursday it was issued in error. The paper is now intact on the journal’s site.

This isn’t the first time the journal has withdrawn a statement that authors couldn’t pay the page charges — we’ve discovered the journal removed a line to that effect from a 2015 retraction notice (although in that case, it left the retraction intact). Page charges, often required by traditional publishers, typically cover printing costs; they differ from article processing charges (APCs) levied by open-access journals, which cover the cost of publishing the paper and making it freely available.

We’ve contacted editors at the journal and its publisher, Taylor & Francis, to try to find out why there are mixed messages about author page charges. A spokesperson for the publisher said it was unable to respond before deadline, but it was looking into the matter:

I can confirm that we are committed to following [Committee on Publication Ethics] guidelines and that we are taking this issue seriously.

In the meantime, here’s what we know.

Continue reading A journal retracted a paper when authors couldn’t pay. Then it retracted the retraction.

Journal to assemble “senior editorial committee” to review paper that led to board resignations

Following heavy criticism of its decision to correct — instead of retract — a paper accused of plagiarism, Scientific Reports is adding an editor’s note to the paper and forming a committee to review the case.

The 2016 paper in question has been accused of plagiarism by a researcher at Johns Hopkins, Michael Beer. Following the initial allegation, the journal decided to correct, not retract, the paper. After we covered the story, nearly two dozen Hopkins researchers threatened to resign if the journal didn’t retract the paper. This week, the journal reaffirmed its initial decision, and the resignations are pouring in.

Yesterday, Suzanne Farley, Executive Editor of Scientific Reports, a Nature Publishing Group journal, sent us a statement:

Continue reading Journal to assemble “senior editorial committee” to review paper that led to board resignations

Newly released AI software writes papers for you — what could go wrong?

This week, we received a press release that caught our attention: A company is releasing software it claims will write manuscripts using researchers’ data. 

The program, dubbed “Manuscript Writer,” uses artificial intelligence (AI) to generate papers, according to the company that created it, sciNote LLC. A spokesperson explained the software generates a first draft the scientist should revise, and won’t write the Discussion, “the most creative and original part of the scientific article.” But can it provide any coherent text?  

According the release from sciNote, Manuscript Writer (an add-on to the company’s Electronic Lab Notebook, or ELN):

Continue reading Newly released AI software writes papers for you — what could go wrong?

Carlo Croce, facing misconduct allegations, accuses former colleague of misconduct

Carlo Croce

Carlo Croce, a cancer researcher who has faced numerous research misconduct allegations, recently accused a former lab member of misconduct. Although an institutional probe did not support that allegation, Croce’s efforts have led to a retraction.

In November 2015, Croce and another cancer researcher at Ohio State University (OSU), Ramiro Garzon, contacted PLOS ONE, alleging that the paper’s corresponding author, Stefan Costinean, published data without their knowledge or permission and without “accurately acknowledging their contributions to the research.” Although the PLOS ONE paper mentioned Croce’s and Garzon’s contributions in the acknowledgements section, the two were not included as co-authors. We have obtained a copy of the report describing OSU’s preliminary probe; it did not find evidence of misconduct, but recommended the paper be retracted for using data without permission. Although Costinean disagreed, the journal has since retracted the paper.

Croce has been on the other side of this process: Seven of his papers have been retracted for issues including manipulation and duplication. After a New York Times article, published in March, explored misconduct allegations against Croce, OSU said the university is “instituting an independent external review.” Croce is currently suing the New York Times, alleging that the newspaper defamed him in the story.

Continue reading Carlo Croce, facing misconduct allegations, accuses former colleague of misconduct